| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 19,050 | $30 | $628.6K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 17,250 | $10 | $172.5K |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 35,600 | $1 | $142.4K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 480 | $90 | $41.2K |
| J0897 | Injection, denosumab, 1 mg | 2,280 | $20 | $41K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 330 | $50 | $15.3K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 130 | $90 | $11.9K |
| J7320 | Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg | 2,350 | $10 | $11.8K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 60 | $170 | $10.4K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 170 | $60 | $10.1K |